CClinicalTrials.gg
RecruitingNCT06995742ANNE One TMRCTUpdated Jun 5, 2025

Effect of ANNE One-Wellue Device Array Use on Staff Bedside Vital Sign Measurement Activity

An interventional study of Device Array Use and Routine Vital Sign Measurement in Vital Sign Evaluation, Vital Sign Monitoring and Sleep Quality, sponsored by Northwestern University. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-05.

Sponsored by Northwestern University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
270
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Randomized controlled trial of a time motion study of time spent obtaining and charting vital signs for inpatients, comparing use of a wireless Bluetooth vital sign array as intervention versus routine vital sign obtainment activity on a general medical floor.

02

Conditions studied

  • Vital Sign Evaluation
  • Vital Sign Monitoring
  • Sleep Quality
  • Provider Behavior
  • Patient Satisfaction

Keywords

  • time motion study
  • vital signs
  • sleep quality
  • inpatient sleep
  • wireless device
  • patient satisfaction
03

In context

Lead sponsor

Northwestern University is the lead sponsor of 1,398 studies on the registry; 201 are open to participants now.

Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Inpatients admitted to Northwestern Memorial Hospital, Feinberg Unit 16 West.

Exclusion criteria

Exclusion Criteria:

  • Primary language other than English, under isolation status, pregnant patients, prisoners, employees or students of the hospital or Northwestern University.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
270 participants (estimated)

Study arms

  • Experimental
    Intervention--Device Array Use

    Inpatients will wear the ANNE One device array for obtainment of vital sign assessments.

    Device: Device Array Use

  • Active comparator
    Control--Routine Vital Sign Obtainment

    Inpatients will have vital signs determined by routine practice, using any other standard of care-accepted method or device.

    Device: Routine Vital Sign Measurement

Interventions

  • DeviceDevice Array Use

    Study participants assigned to the intervention study arm will wear a wireless Bluetooth capable vital sign detection array, with one device externally worn on each of their chest, one finger, and one arm, with healthcare providers using an additional oral temperature probe.

  • DeviceRoutine Vital Sign Measurement

    Study participants randomized to the control arm will have their vital signs obtained by routine means, without use of the wireless vital sign device array.

06

What researchers measure

Primary outcomes

  1. Time Motion Assessment of Time Spent Obtaining and Recording Vital Signs

    The number of seconds spent by a healthcare provider obtaining and charting vital signs will be witnessed and recorded by a research staff member.

    Time frame: Number of seconds spent obtaining and charting vital signs is obtained at 8a daily, for maximum of three days for each study participant, and are added together to equal the total time spent on vital sign assessment.

Secondary outcomes

  1. Sleep Quality of Inpatient Study Participants

    Sleep quality will be determined by use of the Potential Hospital Sleep Disruptions and Noises Questionnaire survey, administered to study participants after a night of study enrolment. The survey scores sleep quality from 1 to 5 with 1 signifying no disruption and 5 signifying extreme disruption.

    Time frame: Survey conducted 24-72 hours after enrolment.

  2. Patient Satisfaction with Inpatient Sleep Quality

    Question 8, "During this hospital stay, how often were you able to get the rest you needed?" of the Hospital Consumer Assessment of Healthcare Providers and Systems post-discharge questionnaire will be collected for study participants. Survey responses include: never, sometimes, usually, always.

    Time frame: Survey sent within a week of hospital discharge and collected within the subsequent thirty days.

  3. Healthcare Provider Experience with the Vital Sign Device Array

    Healthcare providers who use the device array will be surveyed with a Technology Acceptance Method survey to assess usability of the device array.

    Time frame: The electronic survey will be administered twice during the study. Each survey will take approximately ten minutes to complete.

07

Study locations

1 of 2 sites recruiting
  • Feinberg 16 West, Northwestern Memorial Hospital
    Chicago, Illinois 60611, United States
    • Gregory R Smith Jr, MD MS · Contact · g.smith@nm.org · 312-926-5893
    • Gregory R Smith Jr, MD MS · Principal investigator
    Recruiting
  • Northwestern Memorial Hospital
    Chicago, Illinois 60611, United States
    • Gregory (Randy) R Smith Jr, MD MS · Contact · g.smith@nm.org · 312-926-5893
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06995742
Lead sponsor
Northwestern University
Collaborators
University of Minnesota Medical School/University of Minnesota Foundation, Sibel Health Inc.
Responsible party
Gregory Randall Smith Jr (Professor, Northwestern University) — Principal investigator
First posted
May 29, 2025
Start date
Jun 2, 2025
Primary completion
Jul 31, 2026 (estimated)
Completion
Jul 31, 2026 (estimated)
Last update
Jun 5, 2025

Study contacts

Gregory (Randy) R Smith Jr, MD MS
Contact
g.smith@nm.org
312-926-5893
Jane S Kim, MS MEd
Contact
jane.kim@northwestern.edu
312-926-7272
Gregory (Randy) R Smith Jr, MD MS
principal investigator · Northwestern University Feinberg School of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion